

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GDP-mannose metabolic process (GO:0019673) | 6.74775081 |
| 2 | negative regulation of cell aging (GO:0090344) | 6.22987612 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.92834172 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.62587248 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.62587248 |
| 6 | UV protection (GO:0009650) | 5.51088255 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.25813701 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.18829736 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.18829736 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.14385716 |
| 11 | cellular response to ATP (GO:0071318) | 5.09392484 |
| 12 | adenine nucleotide transport (GO:0051503) | 4.99537829 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.79937103 |
| 14 | regulation of skeletal muscle contraction (GO:0014819) | 4.77356429 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.73101993 |
| 16 | purine ribonucleotide transport (GO:0015868) | 4.71584344 |
| 17 | protein carboxylation (GO:0018214) | 4.70402166 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.70402166 |
| 19 | adenosine receptor signaling pathway (GO:0001973) | 4.64998554 |
| 20 | protein retention in ER lumen (GO:0006621) | 4.60221144 |
| 21 | melanin biosynthetic process (GO:0042438) | 4.59128045 |
| 22 | lens fiber cell differentiation (GO:0070306) | 4.53627729 |
| 23 | DNA strand renaturation (GO:0000733) | 4.42161979 |
| 24 | type B pancreatic cell proliferation (GO:0044342) | 4.36615175 |
| 25 | protein heterotrimerization (GO:0070208) | 4.22943457 |
| 26 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.22939974 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.21226153 |
| 28 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.14437565 |
| 29 | kidney mesenchyme development (GO:0072074) | 3.99686902 |
| 30 | positive regulation of histone deacetylation (GO:0031065) | 3.98417967 |
| 31 | melanin metabolic process (GO:0006582) | 3.97260255 |
| 32 | hyaluronan catabolic process (GO:0030214) | 3.89744891 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.87697330 |
| 34 | skin morphogenesis (GO:0043589) | 3.84962737 |
| 35 | rRNA methylation (GO:0031167) | 3.84861512 |
| 36 | thymic T cell selection (GO:0045061) | 3.83989579 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.82146363 |
| 38 | positive regulation of protein kinase C signaling (GO:0090037) | 3.80491327 |
| 39 | nucleotide transmembrane transport (GO:1901679) | 3.80101343 |
| 40 | purine nucleotide transport (GO:0015865) | 3.77019559 |
| 41 | positive T cell selection (GO:0043368) | 3.76733558 |
| 42 | proline biosynthetic process (GO:0006561) | 3.72760155 |
| 43 | respiratory tube development (GO:0030323) | 3.72494863 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.72099430 |
| 45 | negative thymic T cell selection (GO:0045060) | 3.72066132 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69902949 |
| 47 | negative T cell selection (GO:0043383) | 3.68878472 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68855978 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.68855978 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68855978 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68855978 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68855978 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 3.68855978 |
| 54 | nucleoside transmembrane transport (GO:1901642) | 3.67186212 |
| 55 | response to gravity (GO:0009629) | 3.66802796 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 3.64502990 |
| 57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.63289018 |
| 58 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.61090647 |
| 59 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.59088904 |
| 60 | basement membrane organization (GO:0071711) | 3.56431101 |
| 61 | meiotic chromosome segregation (GO:0045132) | 3.56417854 |
| 62 | leukocyte aggregation (GO:0070486) | 3.55198102 |
| 63 | regulation of cell aging (GO:0090342) | 3.53122037 |
| 64 | mannose metabolic process (GO:0006013) | 3.51246400 |
| 65 | T cell selection (GO:0045058) | 3.50528930 |
| 66 | secondary metabolite biosynthetic process (GO:0044550) | 3.45380787 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.44968191 |
| 68 | regulation of synapse structural plasticity (GO:0051823) | 3.44001090 |
| 69 | extracellular matrix assembly (GO:0085029) | 3.40663781 |
| 70 | endocardial cushion development (GO:0003197) | 3.38472417 |
| 71 | estrogen biosynthetic process (GO:0006703) | 3.34705743 |
| 72 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.32721435 |
| 73 | tolerance induction (GO:0002507) | 3.31866689 |
| 74 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.31828923 |
| 75 | response to interleukin-15 (GO:0070672) | 3.30277306 |
| 76 | cell migration involved in heart development (GO:0060973) | 3.29375575 |
| 77 | negative regulation of granulocyte differentiation (GO:0030853) | 3.24531145 |
| 78 | rRNA modification (GO:0000154) | 3.22481657 |
| 79 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.21776747 |
| 80 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.17180640 |
| 81 | base-excision repair, AP site formation (GO:0006285) | 3.15423849 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15147557 |
| 83 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.14522742 |
| 84 | leukocyte cell-cell adhesion (GO:0007159) | 3.10227921 |
| 85 | tooth mineralization (GO:0034505) | 3.10035511 |
| 86 | macrophage activation involved in immune response (GO:0002281) | 3.08946333 |
| 87 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.08654971 |
| 88 | endocytic recycling (GO:0032456) | 3.05277927 |
| 89 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 3.02943697 |
| 90 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.01082158 |
| 91 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.01082158 |
| 92 | response to laminar fluid shear stress (GO:0034616) | 3.00937061 |
| 93 | negative regulation of phagocytosis (GO:0050765) | 3.00275581 |
| 94 | cellular extravasation (GO:0045123) | 3.00045124 |
| 95 | bone trabecula formation (GO:0060346) | 2.99536576 |
| 96 | natural killer cell differentiation (GO:0001779) | 2.98715303 |
| 97 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.97795464 |
| 98 | response to ATP (GO:0033198) | 2.96558065 |
| 99 | lung vasculature development (GO:0060426) | 2.94594616 |
| 100 | histone phosphorylation (GO:0016572) | 2.94579512 |
| 101 | protein maturation by protein folding (GO:0022417) | 2.94157971 |
| 102 | T cell migration (GO:0072678) | 2.93317212 |
| 103 | metanephric mesenchyme development (GO:0072075) | 2.93025751 |
| 104 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.92989417 |
| 105 | establishment of apical/basal cell polarity (GO:0035089) | 2.92802200 |
| 106 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.91122833 |
| 107 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.91122833 |
| 108 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.91122833 |
| 109 | cochlea morphogenesis (GO:0090103) | 2.90984034 |
| 110 | positive regulation of protein deacetylation (GO:0090312) | 2.89093140 |
| 111 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.88695233 |
| 112 | response to muramyl dipeptide (GO:0032495) | 2.88027798 |
| 113 | urinary tract smooth muscle contraction (GO:0014848) | 2.86532157 |
| 114 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.84806199 |
| 115 | actin filament bundle organization (GO:0061572) | 2.83150854 |
| 116 | actin filament bundle assembly (GO:0051017) | 2.83150854 |
| 117 | regulation of T cell tolerance induction (GO:0002664) | 2.82911397 |
| 118 | apoptotic cell clearance (GO:0043277) | 2.80538063 |
| 119 | sex determination (GO:0007530) | 2.80478574 |
| 120 | stress fiber assembly (GO:0043149) | 2.80150685 |
| 121 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.78737613 |
| 122 | COPI coating of Golgi vesicle (GO:0048205) | 2.78559776 |
| 123 | Golgi transport vesicle coating (GO:0048200) | 2.78559776 |
| 124 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.77330715 |
| 125 | negative regulation of bone resorption (GO:0045779) | 2.77169553 |
| 126 | atrioventricular valve morphogenesis (GO:0003181) | 2.77014724 |
| 127 | cell-substrate adherens junction assembly (GO:0007045) | 2.75400122 |
| 128 | focal adhesion assembly (GO:0048041) | 2.75400122 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73539227 |
| 130 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.73367828 |
| 131 | nucleoside transport (GO:0015858) | 2.73310507 |
| 132 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72713290 |
| 133 | positive regulation of interferon-alpha production (GO:0032727) | 2.72255389 |
| 134 | cortical actin cytoskeleton organization (GO:0030866) | 2.72091520 |
| 135 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.72069963 |
| 136 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.71873727 |
| 137 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.71267651 |
| 138 | cellular response to zinc ion (GO:0071294) | 2.70929891 |
| 139 | semaphorin-plexin signaling pathway (GO:0071526) | 2.70418704 |
| 140 | negative regulation of interleukin-12 production (GO:0032695) | 2.68498139 |
| 141 | lung morphogenesis (GO:0060425) | 2.67841444 |
| 142 | positive regulation of Rap GTPase activity (GO:0032854) | 2.66632501 |
| 143 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65726235 |
| 144 | T cell costimulation (GO:0031295) | 2.62208212 |
| 145 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.61653183 |
| 146 | sphingomyelin metabolic process (GO:0006684) | 2.60163058 |
| 147 | interferon-gamma production (GO:0032609) | 2.59109132 |
| 148 | regulation of interferon-alpha production (GO:0032647) | 2.58854145 |
| 149 | sensory perception of taste (GO:0050909) | 2.58100095 |
| 150 | adherens junction assembly (GO:0034333) | 2.57115306 |
| 151 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.56982805 |
| 152 | NIK/NF-kappaB signaling (GO:0038061) | 2.55668847 |
| 153 | response to type I interferon (GO:0034340) | 2.55657123 |
| 154 | lymphocyte costimulation (GO:0031294) | 2.55594464 |
| 155 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.53959734 |
| 156 | cellular response to vitamin (GO:0071295) | 2.53694018 |
| 157 | T cell receptor signaling pathway (GO:0050852) | 2.52550164 |
| 158 | positive regulation of lamellipodium assembly (GO:0010592) | 2.50125468 |
| 159 | negative regulation of interleukin-6 production (GO:0032715) | 2.48996066 |
| 160 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.48493209 |
| 161 | immunoglobulin mediated immune response (GO:0016064) | 2.48465162 |
| 162 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.48243499 |
| 163 | mature B cell differentiation (GO:0002335) | 2.48091605 |
| 164 | germinal center formation (GO:0002467) | 2.47574820 |
| 165 | pinocytosis (GO:0006907) | 2.47261862 |
| 166 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.46972888 |
| 167 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.45457012 |
| 168 | cellular response to interleukin-15 (GO:0071350) | 2.44761690 |
| 169 | cell-substrate junction assembly (GO:0007044) | 2.44627686 |
| 170 | T cell homeostasis (GO:0043029) | 2.44363271 |
| 171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43615841 |
| 172 | positive regulation of tolerance induction (GO:0002645) | 2.43584919 |
| 173 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.42970479 |
| 174 | cellular response to type I interferon (GO:0071357) | 2.42822884 |
| 175 | type I interferon signaling pathway (GO:0060337) | 2.42822884 |
| 176 | positive regulation of catecholamine secretion (GO:0033605) | 2.42242744 |
| 177 | myeloid cell activation involved in immune response (GO:0002275) | 2.42084059 |
| 178 | proline metabolic process (GO:0006560) | 2.41729703 |
| 179 | lymphocyte homeostasis (GO:0002260) | 2.41487554 |
| 180 | neutrophil activation (GO:0042119) | 2.41411146 |
| 181 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.41316992 |
| 182 | B cell homeostasis (GO:0001782) | 2.41124557 |
| 183 | regulation of integrin activation (GO:0033623) | 2.40653146 |
| 184 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.40556436 |
| 185 | growth hormone receptor signaling pathway (GO:0060396) | 2.39978398 |
| 186 | respiratory burst (GO:0045730) | 2.39777886 |
| 187 | regulation of response to interferon-gamma (GO:0060330) | 2.39495836 |
| 188 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.38781925 |
| 189 | response to fluid shear stress (GO:0034405) | 2.38628842 |
| 190 | activated T cell proliferation (GO:0050798) | 2.38482721 |
| 191 | germ cell migration (GO:0008354) | 2.38365939 |
| 192 | T cell proliferation (GO:0042098) | 2.38165357 |
| 193 | positive regulation of lamellipodium organization (GO:1902745) | 2.37681136 |
| 194 | neutrophil activation involved in immune response (GO:0002283) | 2.35164183 |
| 195 | adaptation of signaling pathway (GO:0023058) | 2.35094180 |
| 196 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.34946564 |
| 197 | regulation of granulocyte differentiation (GO:0030852) | 2.34625423 |
| 198 | I-kappaB phosphorylation (GO:0007252) | 2.33147415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.08713941 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79605619 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.52664421 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.51955969 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.44341347 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.22366554 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.15014970 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03127002 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.70940716 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.68861712 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67011187 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.66701707 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66088365 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.55024310 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52546995 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.49086031 |
| 17 | P68_20966046_ChIP-Seq_HELA_Human | 2.45670718 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.45640765 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.40809095 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.38826293 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.37915962 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37578402 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35555952 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.34599403 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.29420290 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28646688 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.24795118 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24720163 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22067732 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.20375903 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.20141562 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19488812 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.17146686 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 2.17111358 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 2.16145674 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.15146104 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11649837 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10664863 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.07044145 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98298977 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.97371237 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.95634607 |
| 43 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.93358981 |
| 44 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.93051619 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92363410 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90228664 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88718590 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87356936 |
| 49 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.82137630 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.80900521 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80126353 |
| 52 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.78459524 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75763095 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.74646984 |
| 55 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.71033191 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.70895672 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70402483 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69791595 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.68447053 |
| 60 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.68147981 |
| 61 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.67764949 |
| 62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.64889115 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.64559579 |
| 64 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63792797 |
| 65 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.63691965 |
| 66 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.63606412 |
| 67 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.62904411 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62217901 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.58711187 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.58267960 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57448360 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56915624 |
| 73 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.56292531 |
| 74 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.55583860 |
| 75 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.54900603 |
| 76 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.54719968 |
| 77 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.53295848 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52649968 |
| 79 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.51731850 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.50058220 |
| 81 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.49475168 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49103455 |
| 83 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.45917605 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45495215 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.43812145 |
| 86 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.43234397 |
| 87 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.42881791 |
| 88 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.42102082 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40889266 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.39582932 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39138344 |
| 92 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.38985915 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38702359 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37412653 |
| 95 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37122058 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.36581231 |
| 97 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.32859691 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30415207 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28425069 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26996627 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26803931 |
| 102 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.26694146 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26417129 |
| 104 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26270661 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26059782 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25725477 |
| 107 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24127072 |
| 108 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23447360 |
| 109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23164073 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23054865 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22331243 |
| 112 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19524061 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18972007 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18262097 |
| 115 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18083252 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18053722 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16343971 |
| 118 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.16027238 |
| 119 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15926714 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15697391 |
| 121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15092700 |
| 122 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15035895 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15003750 |
| 124 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.14936960 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13486178 |
| 126 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.12606848 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11421862 |
| 128 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10201921 |
| 129 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10056120 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09508903 |
| 131 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.09486475 |
| 132 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09454096 |
| 133 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09156618 |
| 134 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07929525 |
| 135 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07879043 |
| 136 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07826619 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07463110 |
| 138 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.07236760 |
| 139 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06996514 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06818427 |
| 141 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06646823 |
| 142 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.06603260 |
| 143 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06566619 |
| 144 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.06513137 |
| 145 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.06139435 |
| 146 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04605620 |
| 147 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04409479 |
| 148 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03324330 |
| 149 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03118821 |
| 150 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03012526 |
| 151 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02419551 |
| 152 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.01859310 |
| 153 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.00975528 |
| 154 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00046047 |
| 155 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99623817 |
| 156 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98952508 |
| 157 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97863736 |
| 158 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97769170 |
| 159 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97582280 |
| 160 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96483493 |
| 161 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96483493 |
| 162 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95102449 |
| 163 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94508222 |
| 164 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.94268814 |
| 165 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93084400 |
| 166 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92571715 |
| 167 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92387634 |
| 168 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90113625 |
| 169 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88228444 |
| 170 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84993489 |
| 171 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84053440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 5.36941084 |
| 2 | MP0001986_abnormal_taste_sensitivity | 3.97730918 |
| 3 | MP0003303_peritoneal_inflammation | 3.40601297 |
| 4 | MP0003136_yellow_coat_color | 3.31291840 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.19208449 |
| 6 | MP0000751_myopathy | 2.97400761 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.91893077 |
| 8 | MP0005409_darkened_coat_color | 2.87762939 |
| 9 | MP0009278_abnormal_bone_marrow | 2.82634610 |
| 10 | MP0001661_extended_life_span | 2.82036062 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.81671109 |
| 12 | MP0005387_immune_system_phenotype | 2.78754858 |
| 13 | MP0001790_abnormal_immune_system | 2.78754858 |
| 14 | MP0000685_abnormal_immune_system | 2.69733790 |
| 15 | MP0001800_abnormal_humoral_immune | 2.58482027 |
| 16 | MP0004510_myositis | 2.55852171 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.52638593 |
| 18 | MP0003436_decreased_susceptibility_to | 2.50857877 |
| 19 | MP0009384_cardiac_valve_regurgitation | 2.44112790 |
| 20 | MP0001188_hyperpigmentation | 2.43729898 |
| 21 | MP0005503_abnormal_tendon_morphology | 2.35176453 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.31020024 |
| 23 | MP0005083_abnormal_biliary_tract | 2.30575230 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.27025465 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.23487962 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.22611187 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.14455502 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.13629475 |
| 29 | MP0005671_abnormal_response_to | 2.13101241 |
| 30 | MP0001819_abnormal_immune_cell | 2.11984396 |
| 31 | MP0000013_abnormal_adipose_tissue | 2.10728827 |
| 32 | * MP0002723_abnormal_immune_serum | 2.08868941 |
| 33 | MP0002419_abnormal_innate_immunity | 2.08572684 |
| 34 | MP0005464_abnormal_platelet_physiology | 2.05043177 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.98160645 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.95089392 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.94282923 |
| 38 | MP0001542_abnormal_bone_strength | 1.94129088 |
| 39 | * MP0002398_abnormal_bone_marrow | 1.93358910 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.93295652 |
| 41 | MP0001873_stomach_inflammation | 1.92079728 |
| 42 | MP0004272_abnormal_basement_membrane | 1.89725633 |
| 43 | * MP0005025_abnormal_response_to | 1.88529147 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.85851267 |
| 45 | MP0004947_skin_inflammation | 1.85687826 |
| 46 | MP0002405_respiratory_system_inflammati | 1.84951501 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.84376035 |
| 48 | MP0005623_abnormal_meninges_morphology | 1.81455604 |
| 49 | * MP0000716_abnormal_immune_system | 1.76430559 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.74776161 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.73088638 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.68396523 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.68396523 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.67983063 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.63289112 |
| 56 | MP0009785_altered_susceptibility_to | 1.61692403 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.60430058 |
| 58 | MP0000750_abnormal_muscle_regeneration | 1.59291278 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.59210304 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.58790605 |
| 61 | * MP0002722_abnormal_immune_system | 1.57699575 |
| 62 | MP0010030_abnormal_orbit_morphology | 1.57286084 |
| 63 | MP0002933_joint_inflammation | 1.53858083 |
| 64 | MP0006082_CNS_inflammation | 1.53659585 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.50411329 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.49110853 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.48787087 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.48373914 |
| 69 | * MP0002429_abnormal_blood_cell | 1.47249435 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.45183529 |
| 71 | * MP0001756_abnormal_urination | 1.44853856 |
| 72 | * MP0002148_abnormal_hypersensitivity_rea | 1.44773409 |
| 73 | MP0002006_tumorigenesis | 1.44492363 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.43233541 |
| 75 | MP0003866_abnormal_defecation | 1.41564781 |
| 76 | MP0005330_cardiomyopathy | 1.36542080 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 1.35174380 |
| 78 | MP0005275_abnormal_skin_tensile | 1.28869044 |
| 79 | MP0003279_aneurysm | 1.28176132 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27758623 |
| 81 | MP0010386_abnormal_urinary_bladder | 1.25976103 |
| 82 | MP0009840_abnormal_foam_cell | 1.25410342 |
| 83 | MP0003091_abnormal_cell_migration | 1.25292594 |
| 84 | MP0000534_abnormal_ureter_morphology | 1.23491502 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.22918257 |
| 86 | MP0001299_abnormal_eye_distance/ | 1.22900418 |
| 87 | MP0002060_abnormal_skin_morphology | 1.21922637 |
| 88 | MP0003724_increased_susceptibility_to | 1.20954105 |
| 89 | MP0003045_fibrosis | 1.20782364 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 1.19941716 |
| 91 | MP0001853_heart_inflammation | 1.19122017 |
| 92 | MP0005023_abnormal_wound_healing | 1.18532569 |
| 93 | MP0005508_abnormal_skeleton_morphology | 1.16945457 |
| 94 | MP0001664_abnormal_digestion | 1.16306155 |
| 95 | MP0005310_abnormal_salivary_gland | 1.15902117 |
| 96 | MP0005332_abnormal_amino_acid | 1.15858198 |
| 97 | MP0003942_abnormal_urinary_system | 1.14344907 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 1.14235083 |
| 99 | MP0001243_abnormal_dermal_layer | 1.14005884 |
| 100 | MP0003183_abnormal_peptide_metabolism | 1.13983914 |
| 101 | MP0001958_emphysema | 1.13648358 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 1.13015345 |
| 103 | MP0004130_abnormal_muscle_cell | 1.11111242 |
| 104 | MP0003828_pulmonary_edema | 1.09834034 |
| 105 | MP0005670_abnormal_white_adipose | 1.09098289 |
| 106 | MP0000747_muscle_weakness | 1.07194864 |
| 107 | MP0001849_ear_inflammation | 1.06644618 |
| 108 | MP0001502_abnormal_circadian_rhythm | 1.06374286 |
| 109 | MP0005174_abnormal_tail_pigmentation | 1.05084273 |
| 110 | MP0008469_abnormal_protein_level | 1.03381245 |
| 111 | MP0010307_abnormal_tumor_latency | 1.02979330 |
| 112 | MP0001348_abnormal_lacrimal_gland | 1.01719543 |
| 113 | MP0001851_eye_inflammation | 1.00337119 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.97462754 |
| 115 | MP0005501_abnormal_skin_physiology | 0.97273790 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.95509077 |
| 117 | MP0000858_altered_metastatic_potential | 0.94268606 |
| 118 | MP0001270_distended_abdomen | 0.93568236 |
| 119 | MP0000343_altered_response_to | 0.93351699 |
| 120 | * MP0003448_altered_tumor_morphology | 0.93271282 |
| 121 | MP0008438_abnormal_cutaneous_collagen | 0.93049335 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.92114756 |
| 123 | MP0000733_abnormal_muscle_development | 0.92040969 |
| 124 | MP0004858_abnormal_nervous_system | 0.91021300 |
| 125 | MP0009250_abnormal_appendicular_skeleto | 0.90992941 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.90180497 |
| 127 | MP0003111_abnormal_nucleus_morphology | 0.89926781 |
| 128 | MP0004084_abnormal_cardiac_muscle | 0.87829089 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.87165520 |
| 130 | MP0002160_abnormal_reproductive_system | 0.86386067 |
| 131 | MP0010630_abnormal_cardiac_muscle | 0.86054869 |
| 132 | MP0002177_abnormal_outer_ear | 0.85790785 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.85371428 |
| 134 | MP0000249_abnormal_blood_vessel | 0.83607341 |
| 135 | MP0002138_abnormal_hepatobiliary_system | 0.83206105 |
| 136 | MP0002928_abnormal_bile_duct | 0.82281899 |
| 137 | MP0003646_muscle_fatigue | 0.82233288 |
| 138 | MP0003941_abnormal_skin_development | 0.81496323 |
| 139 | MP0003795_abnormal_bone_structure | 0.79508452 |
| 140 | MP0005375_adipose_tissue_phenotype | 0.77742074 |
| 141 | MP0000490_abnormal_crypts_of | 0.76322474 |
| 142 | MP0000604_amyloidosis | 0.75888068 |
| 143 | MP0003075_altered_response_to | 0.75593586 |
| 144 | MP0000681_abnormal_thyroid_gland | 0.75552502 |
| 145 | MP0001765_abnormal_ion_homeostasis | 0.75492706 |
| 146 | MP0000537_abnormal_urethra_morphology | 0.74738755 |
| 147 | MP0005166_decreased_susceptibility_to | 0.74423913 |
| 148 | * MP0002136_abnormal_kidney_physiology | 0.74331997 |
| 149 | MP0010368_abnormal_lymphatic_system | 0.72397169 |
| 150 | MP0002295_abnormal_pulmonary_circulatio | 0.71269112 |
| 151 | MP0005167_abnormal_blood-brain_barrier | 0.70875399 |
| 152 | MP0004087_abnormal_muscle_fiber | 0.70675462 |
| 153 | MP0009931_abnormal_skin_appearance | 0.69822106 |
| 154 | MP0005390_skeleton_phenotype | 0.68473692 |
| 155 | MP0003755_abnormal_palate_morphology | 0.68351208 |
| 156 | MP0002932_abnormal_joint_morphology | 0.67716114 |
| 157 | MP0003329_amyloid_beta_deposits | 0.67574375 |
| 158 | MP0005197_abnormal_uvea_morphology | 0.67397686 |
| 159 | MP0006054_spinal_hemorrhage | 0.65706519 |
| 160 | MP0009053_abnormal_anal_canal | 0.65299963 |
| 161 | MP0003385_abnormal_body_wall | 0.65085229 |
| 162 | MP0000049_abnormal_middle_ear | 0.64821964 |
| 163 | MP0002128_abnormal_blood_circulation | 0.64439566 |
| 164 | MP0000358_abnormal_cell_content/ | 0.62676742 |
| 165 | MP0005220_abnormal_exocrine_pancreas | 0.61126384 |
| 166 | MP0002249_abnormal_larynx_morphology | 0.60221244 |
| 167 | MP0002254_reproductive_system_inflammat | 0.58465031 |
| 168 | MP0003137_abnormal_impulse_conducting | 0.58241709 |
| 169 | MP0002115_abnormal_skeleton_extremities | 0.55259010 |
| 170 | MP0000163_abnormal_cartilage_morphology | 0.54485481 |
| 171 | MP0000639_abnormal_adrenal_gland | 0.54355234 |
| 172 | MP0000678_abnormal_parathyroid_gland | 0.54011362 |
| 173 | MP0000470_abnormal_stomach_morphology | 0.53982835 |
| 174 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.53408781 |
| 175 | MP0005595_abnormal_vascular_smooth | 0.52303364 |
| 176 | MP0000367_abnormal_coat/_hair | 0.51379994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.00355774 |
| 2 | Testicular atrophy (HP:0000029) | 4.88614759 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.68602497 |
| 4 | Coronal craniosynostosis (HP:0004440) | 4.60368670 |
| 5 | Cutaneous melanoma (HP:0012056) | 4.58854322 |
| 6 | Annular pancreas (HP:0001734) | 4.42268121 |
| 7 | Turricephaly (HP:0000262) | 4.24583495 |
| 8 | Thin bony cortex (HP:0002753) | 4.23190946 |
| 9 | Joint stiffness (HP:0001387) | 3.95848436 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.93336841 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.82240598 |
| 12 | Rib fusion (HP:0000902) | 3.74229941 |
| 13 | Poikiloderma (HP:0001029) | 3.58167777 |
| 14 | Recurrent viral infections (HP:0004429) | 3.52905683 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.45824797 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.42760938 |
| 17 | Cellulitis (HP:0100658) | 3.38624437 |
| 18 | Bowing of the arm (HP:0006488) | 3.37588210 |
| 19 | Bowed forearm bones (HP:0003956) | 3.37588210 |
| 20 | Colitis (HP:0002583) | 3.34772545 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.30317441 |
| 22 | Inflammation of the large intestine (HP:0002037) | 3.23246884 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.18699354 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.17818222 |
| 25 | Rectovaginal fistula (HP:0000143) | 3.15915337 |
| 26 | Rectal fistula (HP:0100590) | 3.15915337 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.09196944 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.06476338 |
| 29 | Vaginal fistula (HP:0004320) | 3.05715836 |
| 30 | Facial diplegia (HP:0001349) | 3.04367144 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 3.03904823 |
| 32 | Genu recurvatum (HP:0002816) | 3.03415907 |
| 33 | Vascular tortuosity (HP:0004948) | 3.01279549 |
| 34 | Chronic otitis media (HP:0000389) | 2.99571907 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 2.99169335 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 2.96977324 |
| 37 | Aplasia of the musculature (HP:0100854) | 2.96636831 |
| 38 | Ankle contracture (HP:0006466) | 2.93400503 |
| 39 | Verrucae (HP:0200043) | 2.93162214 |
| 40 | Papilloma (HP:0012740) | 2.93162214 |
| 41 | Intestinal fistula (HP:0100819) | 2.93148337 |
| 42 | Hematochezia (HP:0002573) | 2.89092870 |
| 43 | Nasal polyposis (HP:0100582) | 2.88767227 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.87951781 |
| 45 | IgM deficiency (HP:0002850) | 2.82762506 |
| 46 | Akinesia (HP:0002304) | 2.82089490 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.73016734 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.72833926 |
| 49 | Recurrent bronchitis (HP:0002837) | 2.72244358 |
| 50 | Arterial tortuosity (HP:0005116) | 2.70133976 |
| 51 | Aortic aneurysm (HP:0004942) | 2.67488264 |
| 52 | T lymphocytopenia (HP:0005403) | 2.65402095 |
| 53 | Mesangial abnormality (HP:0001966) | 2.65093834 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.64262944 |
| 55 | Pustule (HP:0200039) | 2.64236821 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.62806000 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.61711245 |
| 58 | Facial hemangioma (HP:0000329) | 2.59140376 |
| 59 | Type 1 muscle fiber predominance (HP:0003803) | 2.57713540 |
| 60 | Bladder diverticulum (HP:0000015) | 2.56211368 |
| 61 | Squamous cell carcinoma (HP:0002860) | 2.53154923 |
| 62 | Popliteal pterygium (HP:0009756) | 2.52973571 |
| 63 | Abnormality of T cell number (HP:0011839) | 2.52207988 |
| 64 | Myositis (HP:0100614) | 2.51593045 |
| 65 | Soft skin (HP:0000977) | 2.51009391 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.49031863 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.49031863 |
| 68 | Increased density of long bones (HP:0006392) | 2.48744622 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.41688230 |
| 70 | Recurrent skin infections (HP:0001581) | 2.41503635 |
| 71 | Narrow nasal bridge (HP:0000446) | 2.41174417 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.40885201 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.40693703 |
| 74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40210669 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.40210669 |
| 76 | Aortic dissection (HP:0002647) | 2.39081919 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.37988062 |
| 78 | Delayed epiphyseal ossification (HP:0002663) | 2.37642866 |
| 79 | Rectal prolapse (HP:0002035) | 2.37172662 |
| 80 | Meningitis (HP:0001287) | 2.36586149 |
| 81 | Neonatal onset (HP:0003623) | 2.36492027 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.34262055 |
| 83 | Abnormal platelet function (HP:0011869) | 2.34262055 |
| 84 | Dyschromatopsia (HP:0007641) | 2.32946406 |
| 85 | Mediastinal lymphadenopathy (HP:0100721) | 2.32375392 |
| 86 | Elbow flexion contracture (HP:0002987) | 2.31085972 |
| 87 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.30609021 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30463509 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30463509 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30463509 |
| 91 | Emphysema (HP:0002097) | 2.30262385 |
| 92 | Asymmetric septal hypertrophy (HP:0001670) | 2.29757022 |
| 93 | Follicular hyperkeratosis (HP:0007502) | 2.28694784 |
| 94 | Wormian bones (HP:0002645) | 2.26400625 |
| 95 | Decreased circulating renin level (HP:0003351) | 2.26203525 |
| 96 | Broad metatarsal (HP:0001783) | 2.24870555 |
| 97 | Frequent falls (HP:0002359) | 2.24616795 |
| 98 | Attenuation of retinal blood vessels (HP:0007843) | 2.24303888 |
| 99 | Ulnar deviation of the wrist (HP:0003049) | 2.24101717 |
| 100 | Increased number of teeth (HP:0011069) | 2.23441432 |
| 101 | Abnormality of dentin (HP:0010299) | 2.23246190 |
| 102 | Gastrointestinal stroma tumor (HP:0100723) | 2.19536468 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 2.19212780 |
| 104 | Abnormality of the costochondral junction (HP:0000919) | 2.18999262 |
| 105 | Biconcave vertebral bodies (HP:0004586) | 2.18699274 |
| 106 | Spinal rigidity (HP:0003306) | 2.18642281 |
| 107 | Abnormal albumin level (HP:0012116) | 2.17222572 |
| 108 | Hypoalbuminemia (HP:0003073) | 2.17222572 |
| 109 | Joint hemorrhage (HP:0005261) | 2.16758431 |
| 110 | Abnormality of macrophages (HP:0004311) | 2.16309818 |
| 111 | Abnormality of T cells (HP:0002843) | 2.16012458 |
| 112 | Slender build (HP:0001533) | 2.15942590 |
| 113 | Slender long bone (HP:0003100) | 2.14664787 |
| 114 | Hyperacusis (HP:0010780) | 2.14439123 |
| 115 | Vasculitis (HP:0002633) | 2.14420211 |
| 116 | Gingivitis (HP:0000230) | 2.13548241 |
| 117 | Anteriorly placed anus (HP:0001545) | 2.13374336 |
| 118 | Short nail (HP:0001799) | 2.12443141 |
| 119 | Periodontitis (HP:0000704) | 2.11896211 |
| 120 | Atrophic scars (HP:0001075) | 2.11401931 |
| 121 | Shallow orbits (HP:0000586) | 2.10777572 |
| 122 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.08721332 |
| 123 | Thin ribs (HP:0000883) | 2.07469636 |
| 124 | Osteomyelitis (HP:0002754) | 2.07362953 |
| 125 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.06443248 |
| 126 | Ovoid vertebral bodies (HP:0003300) | 2.06442921 |
| 127 | Macroorchidism (HP:0000053) | 2.06079659 |
| 128 | Restrictive lung disease (HP:0002091) | 2.05909649 |
| 129 | Chest pain (HP:0100749) | 2.05625604 |
| 130 | Increased circulating renin level (HP:0000848) | 2.05497513 |
| 131 | Abnormal trabecular bone morphology (HP:0100671) | 2.05162784 |
| 132 | Spondylolisthesis (HP:0003302) | 2.05086743 |
| 133 | Myocardial infarction (HP:0001658) | 2.05058441 |
| 134 | Systemic lupus erythematosus (HP:0002725) | 2.04295209 |
| 135 | Zonular cataract (HP:0010920) | 2.03684699 |
| 136 | Fragile skin (HP:0001030) | 2.03479306 |
| 137 | Thoracic kyphosis (HP:0002942) | 2.02686696 |
| 138 | Congenital hip dislocation (HP:0001374) | 2.01702452 |
| 139 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01368469 |
| 140 | Obstructive lung disease (HP:0006536) | 2.00440932 |
| 141 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00440932 |
| 142 | Increased IgE level (HP:0003212) | 1.99999694 |
| 143 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99204762 |
| 144 | Chorioretinal atrophy (HP:0000533) | 1.99174070 |
| 145 | Morphological abnormality of the middle ear (HP:0008609) | 1.99058748 |
| 146 | Myotonia (HP:0002486) | 1.97571928 |
| 147 | Choanal stenosis (HP:0000452) | 1.97171153 |
| 148 | Thyroiditis (HP:0100646) | 1.96448193 |
| 149 | Thrombocytosis (HP:0001894) | 1.95527732 |
| 150 | Arterial thrombosis (HP:0004420) | 1.95306762 |
| 151 | Generalized amyotrophy (HP:0003700) | 1.95023403 |
| 152 | Lymphopenia (HP:0001888) | 1.94553241 |
| 153 | Leukocytosis (HP:0001974) | 1.94309658 |
| 154 | Epistaxis (HP:0000421) | 1.94300619 |
| 155 | Patellar aplasia (HP:0006443) | 1.93939229 |
| 156 | Disproportionate tall stature (HP:0001519) | 1.93493573 |
| 157 | Short chin (HP:0000331) | 1.93317160 |
| 158 | Mitral valve prolapse (HP:0001634) | 1.93071849 |
| 159 | Atrioventricular block (HP:0001678) | 1.92924349 |
| 160 | Blue sclerae (HP:0000592) | 1.91216307 |
| 161 | Abnormality of the thoracic spine (HP:0100711) | 1.91124972 |
| 162 | Aneurysm (HP:0002617) | 1.90113405 |
| 163 | Myopathic facies (HP:0002058) | 1.90102598 |
| 164 | Abnormal platelet volume (HP:0011876) | 1.90064954 |
| 165 | Eosinophilia (HP:0001880) | 1.90057558 |
| 166 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89956334 |
| 167 | Nonimmune hydrops fetalis (HP:0001790) | 1.89875027 |
| 168 | Cardiovascular calcification (HP:0011915) | 1.88938051 |
| 169 | Cervical subluxation (HP:0003308) | 1.87267169 |
| 170 | Loss of speech (HP:0002371) | 1.86341508 |
| 171 | Short humerus (HP:0005792) | 1.85611017 |
| 172 | Bowel diverticulosis (HP:0005222) | 1.85521069 |
| 173 | Femoral bowing (HP:0002980) | 1.85037595 |
| 174 | Bicuspid aortic valve (HP:0001647) | 1.84450914 |
| 175 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82771180 |
| 176 | Osteolytic defects of the hand bones (HP:0009699) | 1.82771180 |
| 177 | Hypoventilation (HP:0002791) | 1.82747148 |
| 178 | Hand muscle atrophy (HP:0009130) | 1.82625684 |
| 179 | Ulnar bowing (HP:0003031) | 1.82199063 |
| 180 | Petechiae (HP:0000967) | 1.82198218 |
| 181 | Upper limb amyotrophy (HP:0009129) | 1.81497310 |
| 182 | Distal upper limb amyotrophy (HP:0007149) | 1.81497310 |
| 183 | Persistence of primary teeth (HP:0006335) | 1.80885028 |
| 184 | Severe short stature (HP:0003510) | 1.79481201 |
| 185 | Striae distensae (HP:0001065) | 1.77942303 |
| 186 | Mitral stenosis (HP:0001718) | 1.77570129 |
| 187 | Dilatation of the ascending aorta (HP:0005111) | 1.76865972 |
| 188 | IgA deficiency (HP:0002720) | 1.76743906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.83111623 |
| 2 | MAP4K1 | 4.25264544 |
| 3 | MYLK | 3.75289561 |
| 4 | TRIB3 | 3.73529574 |
| 5 | PKN2 | 3.15678777 |
| 6 | EEF2K | 2.87037919 |
| 7 | NTRK1 | 2.86505549 |
| 8 | MAP3K10 | 2.82724118 |
| 9 | ERN1 | 2.81561008 |
| 10 | WNK4 | 2.72610284 |
| 11 | EPHA2 | 2.67631920 |
| 12 | TTN | 2.30786535 |
| 13 | EPHB2 | 2.26287758 |
| 14 | TYK2 | 2.19241913 |
| 15 | TGFBR2 | 2.03502883 |
| 16 | STK10 | 1.96337054 |
| 17 | JAK3 | 1.93951322 |
| 18 | ZAP70 | 1.88282218 |
| 19 | MST1R | 1.85538816 |
| 20 | TESK2 | 1.83514924 |
| 21 | SIK2 | 1.83099606 |
| 22 | MET | 1.80490585 |
| 23 | EPHB1 | 1.77240660 |
| 24 | GRK6 | 1.75609793 |
| 25 | PTK6 | 1.74442966 |
| 26 | JAK1 | 1.70471689 |
| 27 | TBK1 | 1.70017847 |
| 28 | LRRK2 | 1.64940969 |
| 29 | CAMK1D | 1.63345028 |
| 30 | FGFR4 | 1.58741802 |
| 31 | MUSK | 1.58657402 |
| 32 | ADRBK1 | 1.53564122 |
| 33 | RIPK1 | 1.51224370 |
| 34 | CSF1R | 1.49355426 |
| 35 | ITK | 1.46923976 |
| 36 | CDK12 | 1.46038109 |
| 37 | CAMK1G | 1.45270795 |
| 38 | KIT | 1.44330967 |
| 39 | HCK | 1.40086783 |
| 40 | BTK | 1.37669744 |
| 41 | MAP2K6 | 1.36261193 |
| 42 | PAK2 | 1.36129011 |
| 43 | BLK | 1.34652808 |
| 44 | SMG1 | 1.34471014 |
| 45 | RIPK4 | 1.33075793 |
| 46 | FGFR3 | 1.32921338 |
| 47 | TXK | 1.31746310 |
| 48 | CSK | 1.31697499 |
| 49 | SYK | 1.31377331 |
| 50 | MAP3K14 | 1.27760747 |
| 51 | FES | 1.22454620 |
| 52 | MAP3K13 | 1.22060777 |
| 53 | IRAK4 | 1.21133683 |
| 54 | DMPK | 1.19278233 |
| 55 | IKBKE | 1.18915521 |
| 56 | STK16 | 1.14609586 |
| 57 | LIMK1 | 1.13781420 |
| 58 | TESK1 | 1.13586606 |
| 59 | PRKD3 | 1.13013628 |
| 60 | SIK1 | 1.11923268 |
| 61 | PRKCH | 1.11693508 |
| 62 | MAP2K3 | 1.10962094 |
| 63 | TAOK3 | 1.09199057 |
| 64 | ILK | 1.07783153 |
| 65 | ABL2 | 1.07607063 |
| 66 | STK38 | 1.05365215 |
| 67 | LCK | 1.04392156 |
| 68 | DDR2 | 1.00055433 |
| 69 | GRK7 | 0.96292728 |
| 70 | MAP3K7 | 0.94729957 |
| 71 | JAK2 | 0.94197446 |
| 72 | MARK3 | 0.91990745 |
| 73 | PIM2 | 0.90161079 |
| 74 | PDGFRB | 0.85170423 |
| 75 | WNK1 | 0.84542334 |
| 76 | PAK1 | 0.84497489 |
| 77 | DYRK1B | 0.83725386 |
| 78 | PDGFRA | 0.82685264 |
| 79 | DAPK3 | 0.82207900 |
| 80 | IKBKB | 0.81871622 |
| 81 | NME2 | 0.81362094 |
| 82 | ROCK1 | 0.79832789 |
| 83 | PIK3CG | 0.77150099 |
| 84 | HIPK2 | 0.76737222 |
| 85 | BMX | 0.76629317 |
| 86 | TLK1 | 0.76086209 |
| 87 | CLK1 | 0.76021025 |
| 88 | TAOK2 | 0.74647995 |
| 89 | MELK | 0.73337075 |
| 90 | TRPM7 | 0.72731466 |
| 91 | IRAK3 | 0.72717209 |
| 92 | PDK1 | 0.72710245 |
| 93 | TEC | 0.72240958 |
| 94 | FLT3 | 0.71882674 |
| 95 | RPS6KA4 | 0.71596341 |
| 96 | IRAK2 | 0.71398128 |
| 97 | CDK8 | 0.71258992 |
| 98 | PRKG2 | 0.71174297 |
| 99 | RET | 0.71086974 |
| 100 | AURKA | 0.70941085 |
| 101 | PAK4 | 0.70582175 |
| 102 | CHUK | 0.69964680 |
| 103 | CDC42BPA | 0.69470791 |
| 104 | ERBB4 | 0.69024574 |
| 105 | ALK | 0.68500147 |
| 106 | LATS2 | 0.68108858 |
| 107 | PAK6 | 0.67718488 |
| 108 | GRK5 | 0.67575122 |
| 109 | PIM1 | 0.67149169 |
| 110 | ADRBK2 | 0.66309033 |
| 111 | CDK15 | 0.66046891 |
| 112 | MAP3K3 | 0.65472351 |
| 113 | KDR | 0.63972362 |
| 114 | SGK3 | 0.62972707 |
| 115 | TAOK1 | 0.61970279 |
| 116 | MTOR | 0.61675371 |
| 117 | BCKDK | 0.61544230 |
| 118 | CDK11A | 0.61095024 |
| 119 | PTK2B | 0.60524990 |
| 120 | PDK2 | 0.60317869 |
| 121 | CDK18 | 0.59601822 |
| 122 | PRKD2 | 0.58758404 |
| 123 | LYN | 0.58378371 |
| 124 | CDK6 | 0.58083656 |
| 125 | MAP2K2 | 0.56089077 |
| 126 | MAP2K1 | 0.55522202 |
| 127 | RPS6KA2 | 0.55308568 |
| 128 | PRKD1 | 0.53227884 |
| 129 | PDPK1 | 0.53222872 |
| 130 | LMTK2 | 0.51447874 |
| 131 | AKT2 | 0.51265978 |
| 132 | MAPK12 | 0.49783231 |
| 133 | ICK | 0.49341015 |
| 134 | CDK4 | 0.48613970 |
| 135 | MARK2 | 0.48409608 |
| 136 | RPS6KA6 | 0.48384676 |
| 137 | MAP3K11 | 0.48190779 |
| 138 | PRKCQ | 0.48186862 |
| 139 | NEK9 | 0.48130574 |
| 140 | NEK2 | 0.47826542 |
| 141 | EPHA3 | 0.46689845 |
| 142 | TNK2 | 0.45059993 |
| 143 | EGFR | 0.44355503 |
| 144 | RPS6KC1 | 0.43998349 |
| 145 | RPS6KL1 | 0.43998349 |
| 146 | CDK14 | 0.43561205 |
| 147 | STK4 | 0.43087282 |
| 148 | SCYL2 | 0.42642515 |
| 149 | CDK7 | 0.42422612 |
| 150 | CDK9 | 0.42245554 |
| 151 | BUB1 | 0.40971300 |
| 152 | MAP3K8 | 0.40461864 |
| 153 | FYN | 0.39163796 |
| 154 | NLK | 0.38124420 |
| 155 | PLK1 | 0.36744985 |
| 156 | PTK2 | 0.36565058 |
| 157 | MAPK11 | 0.36522448 |
| 158 | FGR | 0.36520954 |
| 159 | ROCK2 | 0.36050950 |
| 160 | TIE1 | 0.35674189 |
| 161 | MAPKAPK3 | 0.34409249 |
| 162 | MOS | 0.34331101 |
| 163 | CAMKK1 | 0.32604399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 4.79584806 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.47967261 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.14983283 |
| 4 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.72692134 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.65812253 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.65662695 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.55006361 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38660733 |
| 9 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.27196804 |
| 10 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 2.27000964 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.23177077 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.96151667 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.82964950 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.80524644 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.79830308 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.74442001 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.72900733 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.68833735 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66527132 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66424341 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64389273 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63739340 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.63053476 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62508843 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.61801424 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.58519109 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.57068701 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56525005 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54134634 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.50096690 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.49233317 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48963845 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48693629 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48405351 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47064318 |
| 36 | Bladder cancer_Homo sapiens_hsa05219 | 1.46153158 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45797918 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45360909 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.44380082 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42135939 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40049764 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39919356 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.37361743 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34966244 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34391604 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.33707367 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.32705372 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32344611 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.30798784 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28039910 |
| 51 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.27914211 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.25014007 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 1.23554037 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.22412695 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 1.21084979 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19471966 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.18341018 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.18158937 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 1.18107615 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17940577 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17677149 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16721894 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 1.15330908 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 1.12398533 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04904622 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04543025 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03059828 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02557180 |
| 69 | Malaria_Homo sapiens_hsa05144 | 1.02124215 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.02066935 |
| 71 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.99816843 |
| 72 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99460007 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99257551 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.99027872 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.98305878 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95072655 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.93679308 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.93263468 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91874362 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.91692311 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90154931 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88214460 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87287659 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86036458 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84979422 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84073337 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83992965 |
| 88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81660272 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.81503763 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81281553 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.80990082 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.80086014 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79545091 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79456142 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79350302 |
| 96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78954636 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.78263536 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78194538 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77912402 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.76556207 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74839883 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.74620103 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73103683 |
| 104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72986888 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72906585 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71767873 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71272369 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71100466 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70922400 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68837475 |
| 111 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.66623925 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65916293 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65228318 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64622486 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63410800 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.62781298 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62581544 |
| 118 | Gap junction_Homo sapiens_hsa04540 | 0.62220870 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61914245 |
| 120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61692536 |
| 121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59685586 |
| 122 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59542858 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59537521 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59125329 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58101966 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57681197 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57527958 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57322172 |
| 129 | Cocaine addiction_Homo sapiens_hsa05030 | 0.56597032 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56538992 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55630305 |
| 132 | Prostate cancer_Homo sapiens_hsa05215 | 0.54661782 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53980624 |
| 134 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52788930 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48528347 |
| 136 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48514431 |
| 137 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48428356 |
| 138 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48326157 |
| 139 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47948233 |
| 140 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46575528 |
| 141 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46485449 |
| 142 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46192038 |
| 143 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43256208 |
| 144 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41105164 |
| 145 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37614723 |
| 146 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36476333 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36001981 |
| 148 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34885309 |
| 149 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33434026 |
| 150 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.32154010 |
| 151 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31600999 |
| 152 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29797844 |
| 153 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29756063 |
| 154 | Axon guidance_Homo sapiens_hsa04360 | 0.29478479 |
| 155 | Tight junction_Homo sapiens_hsa04530 | 0.27111868 |
| 156 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25788227 |
| 157 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25625785 |
| 158 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25272229 |
| 159 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.22859397 |
| 160 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22126515 |
| 161 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20376946 |
| 162 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.20144723 |
| 163 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.19558594 |
| 164 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18927911 |

